163 related articles for article (PubMed ID: 26999003)
1. The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α.
Ali HO; Arroyo AB; González-Conejero R; Stavik B; Iversen N; Sandset PM; Martínez C; Skretting G
J Thromb Haemost; 2016 Jun; 14(6):1226-37. PubMed ID: 26999003
[TBL] [Abstract][Full Text] [Related]
2. Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens.
B Arroyo A; Salloum-Asfar S; Pérez-Sánchez C; Teruel-Montoya R; Navarro S; García-Barberá N; Luengo-Gil G; Roldán V; Hansen JB; López-Pedrera C; Vicente V; González-Conejero R; Martínez C
Sci Rep; 2017 Feb; 7():43500. PubMed ID: 28240250
[TBL] [Abstract][Full Text] [Related]
3. Micro-ribonucleic Acid 494 regulation of protein S expression.
Tay JW; Romeo G; Hughes QW; Baker RI
J Thromb Haemost; 2013 Aug; 11(8):1547-55. PubMed ID: 23789915
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen induced downregulation of TFPI expression is mediated by ERα.
Ali HO; Stavik B; Dørum E; Iversen N; Sandset PM; Skretting G
Thromb Res; 2014 Jul; 134(1):138-43. PubMed ID: 24785473
[TBL] [Abstract][Full Text] [Related]
5. Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region.
Ali HO; Stavik B; Myklebust CF; Andersen E; Dahm AE; Iversen N; Sandset PM; Skretting G
PLoS One; 2016; 11(3):e0152114. PubMed ID: 26999742
[TBL] [Abstract][Full Text] [Related]
6. Low abundance of TFPI-2 by both promoter methylation and miR-27a-3p regulation is linked with poor clinical outcome in gastric cancer.
Geng G; Liu X; Xu A; Lu Z; Chen K; He J; Qi D; Yuan X
J Gene Med; 2020 May; 22(5):e3166. PubMed ID: 31984574
[TBL] [Abstract][Full Text] [Related]
7. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
Zhao W; Zhang X; Liu J; Sun B; Tang H; Zhang H
Oncol Rep; 2016 Dec; 36(6):3691-3699. PubMed ID: 27779715
[TBL] [Abstract][Full Text] [Related]
8. Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1.
Dahm AE; Iversen N; Birkenes B; Ree AH; Sandset PM
BMC Cardiovasc Disord; 2006 Oct; 6():40. PubMed ID: 17029634
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
Ljepoja B; García-Roman J; Sommer AK; Wagner E; Roidl A
Breast; 2019 Feb; 43():31-38. PubMed ID: 30415143
[TBL] [Abstract][Full Text] [Related]
10. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples.
Xiong J; Yu D; Wei N; Fu H; Cai T; Huang Y; Wu C; Zheng X; Du Q; Lin D; Liang Z
FEBS J; 2010 Apr; 277(7):1684-94. PubMed ID: 20180843
[TBL] [Abstract][Full Text] [Related]
11. Estrogen induced expression of tissue factor pathway inhibitor-2 in MCF7 cells involves lysine-specific demethylase 1.
Andresen MS; Ali HO; Myklebust CF; Sandset PM; Stavik B; Iversen N; Skretting G
Mol Cell Endocrinol; 2017 Mar; 443():80-88. PubMed ID: 28088469
[TBL] [Abstract][Full Text] [Related]
12. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
13. Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.
Cui XY; Tinholt M; Stavik B; Dahm AE; Kanse S; Jin Y; Seidl S; Sahlberg KK; Iversen N; Skretting G; Sandset PM
J Thromb Haemost; 2016 Feb; 14(2):387-96. PubMed ID: 26598923
[TBL] [Abstract][Full Text] [Related]
14. TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells.
Stavik B; Skretting G; Olstad OK; Sletten M; Dehli Vigeland M; Sandset PM; Iversen N
PLoS One; 2012; 7(10):e47184. PubMed ID: 23071754
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
Li X; Mertens-Talcott SU; Zhang S; Kim K; Ball J; Safe S
Endocrinology; 2010 Jun; 151(6):2462-73. PubMed ID: 20382698
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
18. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer.
Cai B; Chen W; Pan Y; Chen H; Zhang Y; Weng Z; Li Y
Prostate; 2017 Jul; 77(10):1057-1065. PubMed ID: 28631332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
